Podcast appearances and mentions of eileen m o'reilly

Dr Eileen M O'Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer.

Dr Eileen M O'Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer.

Dr Eileen M O'Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer.

Optimizing the Management of Metastatic Pancreatic Cancer | Faculty Presentation 2: Current and Future Role of Biomarker-Based Decision-Making for Metastatic Pancreatic Cancer CME information and select publications

Dr Eileen M O'Reilly from Memorial Sloan Kettering Cancer Center in New York City and Dr Zev A Wainberg from the UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss approved and novel treatment approaches for metastatic pancreatic cancer moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://researchtopractice.com/InsideTheIssue2023/mPancreatic)

In this episode, Eileen M. O'Reilly, MD, and Naureen Starling, MD, FRCP,  discuss emerging therapeutic strategies involving PARP inhibitor therapy in the treatment of pancreatic cancer. Topics include:Current treatment landscape and testing in the United States vs the United Kingdom  Testing for molecular subgroups beyond BRCAmUsing PARP inhibitors in earlier stages of the diseaseLearning from other cancers, such as prostate, breast, and ovarian  Presenters:Eileen M. O'Reilly, MDWinthrop Rockefeller Chair in Medical OncologySection Head, Hepatopancreaticobiliary/Neuroendocrine CancersGastrointestinal Oncology ServiceAssociate DirectorDavid M. Rubenstein Center for Pancreatic CancerAttending Physician, MemberMemorial Sloan Kettering Cancer CenterProfessor of MedicineWeill Medical CollegeNew York, New York, USANaureen Starling, MD, FRCPAssociate Director of Clinical ResearchDepartment of GI CancersConsultant Medical Oncologist, GI CancersThe Royal Marsden HospitalLondon, United KingdomContent based on an online CME program supported by an educational grant from AstraZeneca.Link to full program:https://bit.ly/3s6AnSz

Featuring perspectives from Drs Tanios Bekaii-Saab, Eileen M O'Reilly, Philip A Philip and Kim A Reiss Binder, including the following topics: Introduction (0:00) First- and Second-Line Systemic Treatments for Hepatocellular Carcinoma (2:03) Treatment Strategies and Genomic Testing in Pancreatic Cancer (30:46) Roles of Genetic Testing and Targeted Therapy in the Treatment of Cholangiocarcinoma (1:15:04) CME information and select publications

A special audio program developed from a series of webinars held in conjunction with the 2021 ASCO Annual Meeting. Featuring perspectives from Drs Tanios Bekaii-Saab, Eileen M O'Reilly, Kim A Reiss Binder and Philip A Philip.

A special audio program developed from a series of webinars held in conjunction with the 2021 ASCO Annual Meeting. Featuring perspectives from Drs Tanios Bekaii-Saab, Eileen M O'Reilly, Kim A Reiss Binder and Philip A Philip.

A special audio program developed from a series of webinars held in conjunction with the 2021 ASCO Annual Meeting. Featuring perspectives from Drs Tanios Bekaii-Saab, Eileen M O'Reilly, Kim A Reiss Binder and Philip A Philip.

Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Hepatocellular Carcinoma and Pancreatic Cancer — Faculty Presentation 3: Optimal Management of Localized and Advanced Pancreatic Cancer — Dr O'Reilly CME information and select publications

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in acute myeloid leukemia and myelodysplastic syndromes, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung cancer and multiple myeloma. Featuring perspectives from Drs Kenneth C Anderson, Joaquim Bellmunt, D Ross Camidge, Harry Paul Erba, Rami Komrokji, Benjamin Levy, Wells A Messersmith, Craig Moskowitz, Ruth O'Regan, Eileen M O'Reilly, Sumanta Kumar Pal, Noopur Raje, Jeff Sharman and Tiffany A Traina, moderated by Dr Neil Love.

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in gastrointestinal cancers. Featuring perspectives from Drs Wells A Messersmith and Eileen M O'Reilly, including the following topics: Introduction  Colorectal Cancer  Gastric, Gastroesophageal and Esophageal Cancers  Hepatocellular Cancer  Pancreatic Adenocarcinoma  CME information and select publications  

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in acute myeloid leukemia and myelodysplastic syndromes, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung cancer and multiple myeloma. Featuring perspectives from Drs Kenneth C Anderson, Joaquim Bellmunt, D Ross Camidge, Harry Paul Erba, Rami Komrokji, Benjamin Levy, Wells A Messersmith, Craig Moskowitz, Ruth O'Regan, Eileen M O'Reilly, Sumanta Kumar Pal, Noopur Raje, Jeff Sharman and Tiffany A Traina, moderated by Dr Neil Love.

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in acute myeloid leukemia and myelodysplastic syndromes, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung cancer and multiple myeloma. Featuring perspectives from Drs Kenneth C Anderson, Joaquim Bellmunt, D Ross Camidge, Harry Paul Erba, Rami Komrokji, Benjamin Levy, Wells A Messersmith, Craig Moskowitz, Ruth O'Regan, Eileen M O'Reilly, Sumanta Kumar Pal, Noopur Raje, Jeff Sharman and Tiffany A Traina, moderated by Dr Neil Love.

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in acute myeloid leukemia and myelodysplastic syndromes, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung cancer and multiple myeloma. Featuring perspectives from Drs Kenneth C Anderson, Joaquim Bellmunt, D Ross Camidge, Harry Paul Erba, Rami Komrokji, Benjamin Levy, Wells A Messersmith, Craig Moskowitz, Ruth O'Regan, Eileen M O'Reilly, Sumanta Kumar Pal, Noopur Raje, Jeff Sharman and Tiffany A Traina, moderated by Dr Neil Love.

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in acute myeloid leukemia and myelodysplastic syndromes, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung cancer and multiple myeloma. Featuring perspectives from Drs Kenneth C Anderson, Joaquim Bellmunt, D Ross Camidge, Harry Paul Erba, Rami Komrokji, Benjamin Levy, Wells A Messersmith, Craig Moskowitz, Ruth O'Regan, Eileen M O'Reilly, Sumanta Kumar Pal, Noopur Raje, Jeff Sharman and Tiffany A Traina, moderated by Dr Neil Love.

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in acute myeloid leukemia and myelodysplastic syndromes, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung cancer and multiple myeloma. Featuring perspectives from Drs Kenneth C Anderson, Joaquim Bellmunt, D Ross Camidge, Harry Paul Erba, Rami Komrokji, Benjamin Levy, Wells A Messersmith, Craig Moskowitz, Ruth O'Regan, Eileen M O'Reilly, Sumanta Kumar Pal, Noopur Raje, Jeff Sharman and Tiffany A Traina, moderated by Dr Neil Love.

Proceedings from a daylong symposium hosted in partnership with Medical Oncology Association of Southern California, featuring key clinical presentations and papers in acute myeloid leukemia and myelodysplastic syndromes, breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, lung cancer and multiple myeloma. Featuring perspectives from Drs Kenneth C Anderson, Joaquim Bellmunt, D Ross Camidge, Harry Paul Erba, Rami Komrokji, Benjamin Levy, Wells A Messersmith, Craig Moskowitz, Ruth O'Regan, Eileen M O'Reilly, Sumanta Kumar Pal, Noopur Raje, Jeff Sharman and Tiffany A Traina, moderated by Dr Neil Love.

A special audio program from a CME webinar held in partnership with the American Society of Clinical Oncology. Featuring perspectives from Drs Tanios Bekaii-Saab, Eileen M O'Reilly, Philip A Philip and Alan P Venook.

A special audio program from a CME webinar held in partnership with the American Society of Clinical Oncology. Featuring perspectives from Drs Tanios Bekaii-Saab, Eileen M O'Reilly, Philip A Philip and Alan P Venook.

Proceedings from a CME symposium held at the 2019 ASCO Annual Meeting. Featuring perspectives from Prof Dirk Arnold and Drs Tanios Bekaii-Saab, Joseph Chao, Anthony El-Khoueiry, Richard S Finn, Yelena Y Janjigian, Scott Kopetz and Eileen M O'Reilly. Introduction (00:00) Program overview: Dr Love Hepatocellular Carcinoma (HCC) — Dr El-Khoueiry and Dr Finn (2:01) Case (Dr Gujja): A man in his mid-70s with Child-Pugh A multifocal HCC and a tumor thrombus in the midhepatic vein extending into the floor of the right atrium (2:12) Case (Dr Park): A woman in her early 70s with Child-Pugh B HCC who developed hand-foot syndrome and required a dose reduction while receiving first-line sorafenib and now has progressive disease (16:11) Pancreatic Adenocarcinoma (PAD) — Dr Bekaii-Saab and Dr O'Reilly (41:01) Case (Dr Ibrahim): A man in his late 50s with symptomatic metastatic PAD who experienced a dramatic response to modified FOLFIRINOX (52:14) Cases (Dr Park and Dr Morganstein): Elderly patients with metastatic PAD, poor performance status and disease progression on nab paclitaxel/gemcitabine (1:00:22) Case (Dr Gujja): A woman in her late 60s with metastatic PAD and a germline BRCA2 mutation (1:06:00) Gastric/Gastroesophageal (GEJ) Cancers — Dr Chao and Dr Janjigian (1:20:30) Case (Dr Favaro): A man in his late 30s with HER2-positive metastatic gastric cancer who received paclitaxel/ramucirumab after disease progression and worsening neuropathy on FOLFOX/trastuzumab (1:35:52) Case (Dr Morganstein): A man in his mid-60s with microsatellite-stable, PD-L1-negative metastatic GEJ cancer who attained a complete response to second-line nivolumab (1:39:34) Colorectal Cancer (CRC) — Prof Arnold and Dr Kopetz (1:52:56) Case (Dr Morganstein): A woman in her early 40s with widespread RAS wild-type, microsatellite-stable, left-sided metastatic CRC (mCRC) (1:57:43) Case (Dr Ibrahim): A woman in her late 70s with MSI-high mCRC who refused chemotherapy and experienced a completed response to pembrolizumab (2:04:01) Case (Dr Favaro): A woman in her late 80s with RAS wild-type, microsatellite-stable, right-sided mCRC with a BRAF V600E tumor mutation who received BRAF-targeted therapy (2:13:49) Select publications  

Video proceedings from the first in a series of 6 integrated symposia held at the 2019 ONS Annual Congress. Featuring perspectives from Ms Jessica Mitchell, Dr Eileen M O'Reilly, Dr Philip A Philip and Ms Amanda Wagner. Introduction 0m0s Program overview: Dr Love Colorectal Cancer (CRC) (5:43) Case (Ms Wagner): A man in his mid-70s with metastatic appendiceal carcinoma who received third-line TAS-102 after disease progression on FOLFIRI/bevacizumab and FOLFOX/bevacizumab (8:11) Case (Ms Mitchell): A man in his early 40s with MSI-high metastatic CRC who experienced a dramatic response to pembrolizumab (29:59) Hepatocellular Carcinoma (HCC) (36:14) Case (Ms Wagner): A man in his mid-40s with metastatic HCC who developed hand-foot syndrome while receiving sorafenib (38:21) Case (Ms Mitchell): A woman in her mid-60s with metastatic HCC who had a good response to nivolumab but developed arthralgias (58:07) Pancreatic Cancer (1:04:33) Case (Ms Mitchell): A woman in her mid-70s with locally advanced pancreatic cancer who received neoadjuvant FOLFIRINOX (1:04:47) Case (Ms Wagner): A man in his mid-60s with metastatic pancreatic cancer who received nab paclitaxel/gemcitabine and nal-IRI (1:12:13) Gastroesophageal Cancers (1:20:20) Case (Ms Wagner): A man in his early 70s with metastatic esophageal adenocarcinoma who received FOLFOX followed by paclitaxel/ramucirumab upon disease progression (1:20:43) Case (Ms Mitchell): A woman in her early 60s with metastatic gastric cancer who experienced an excellent response to pembrolizumab but developed autoimmune hypothyroidism (1:24:02) Select publications

Clinical Investigators Provide Perspectives on Actual Patients with Pancreatic Cancer. Featuring Andrew E Hendifar, MD, Eileen M O'Reilly, MD, Philip A Philip, MD, PhD and Margaret A Tempero, MD. Moderated by Neil Love, MD. Produced by Research To Practice.

Clinical Investigators Provide Perspectives on Actual Patients with Pancreatic Cancer. Featuring Andrew E Hendifar, MD, Eileen M O'Reilly, MD, Philip A Philip, MD, PhD and Margaret A Tempero, MD. Moderated by Neil Love, MD. Produced by Research To Practice.

  Faculty presentations from a CME symposium held at the 2019 Gastrointestinal Cancers Symposium. Featuring perspectives from Drs Andrew E Hendifar, Eileen M O'Reilly, Philip A Philip and Margaret A Tempero: Available and Emerging Research Guiding the Treatment of Resectable or Borderline Resectable Pancreatic Adenocarcinoma (PAD) — Dr Tempero (0:00) Patient- and Disease-Specific Factors Informing the Selection of Therapy for Locally Advanced, Unresectable PAD; Selection of First-Line Treatment for Metastatic Disease — Dr Philip (8:24) Optimal Management of Metastatic Disease After Progression on First-Line Therapy — Dr O'Reilly (17:24) Novel Agents and Strategies Under Investigation — Dr Hendifar (25:21) Select publications

Featuring key slides from the most important recent gastrointestinal cancer presentations and publications and video interviews with Dr Tanios Bekaii-Saab and Dr Eileen M O'Reilly. | For more information, visit: http://www.researchtopractice.com/YIROnDemand18/GI

Featuring key slides from the most important recent gastrointestinal cancer presentations and publications and video interviews with Dr Tanios Bekaii-Saab and Dr Eileen M O'Reilly. | For more information, visit: http://www.researchtopractice.com/YIROnDemand18/GI

Featuring key slides from the most important recent gastrointestinal cancer presentations and publications and video interviews with Dr Tanios Bekaii-Saab and Dr Eileen M O'Reilly. | For more information, visit: http://www.researchtopractice.com/YIROnDemand18/GI

Featuring key slides from the most important recent gastrointestinal cancer presentations and publications and video interviews with Dr Tanios Bekaii-Saab and Dr Eileen M O'Reilly. | For more information, visit: http://www.researchtopractice.com/YIROnDemand18/GI

Clinical Investigators Provide Their Perspectives on Current Cases and Clinical Issues in the Management of Colorectal, Gastric and Pancreatic Cancer. Featuring interviews with Axel Grothey, MD and Eileen M O'Reilly, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.

Clinical Investigators Provide Their Perspectives on Current Cases and Clinical Issues in the Management of Colorectal, Gastric and Pancreatic Cancer. Featuring interviews with Axel Grothey, MD and Eileen M O'Reilly, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Featuring interviews with David H Ilson, MD, PhD, Eric Van Cutsem, MD, PhD, Eileen M O'Reilly, MD and Herbert I Hurwitz, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Featuring interviews with David H Ilson, MD, PhD, Eric Van Cutsem, MD, PhD, Eileen M O'Reilly, MD and Herbert I Hurwitz, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

Conversations with Oncology Investigators. Proceedings from a Clinical Investigator Think Tank featuring Johanna C Bendell, Charles S Fuchs, Richard M Goldberg, J Randolph Hecht, Eileen M O'Reilly and Philip A Philip. Moderated by Neil Love, MD. Produced by Research To Practice.

Conversations with Oncology Investigators. Proceedings from a Clinical Investigator Think Tank featuring Johanna C Bendell, Charles S Fuchs, Richard M Goldberg, J Randolph Hecht, Eileen M O'Reilly and Philip A Philip. Moderated by Neil Love, MD. Produced by Research To Practice.

Conversations with Oncology Investigators. Proceedings from a Clinical Investigator Think Tank featuring Johanna C Bendell, MD, Charles S Fuchs, MD, MPH, Richard M Goldberg, MD, J Randolf Hecht, MD, Eileen M O'Reilly, MD and Philip A Philip, MD, PhD. Moderated by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

Conversations with Oncology Investigators. Proceedings from a Clinical Investigator Think Tank featuring Johanna C Bendell, MD, Charles S Fuchs, MD, MPH, Richard M Goldberg, MD, J Randolf Hecht, MD, Eileen M O'Reilly, MD and Philip A Philip, MD, PhD. Moderated by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

ResearchToPractice.com/GICU210 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Featuring interviews with Eric Van Cutsem, MD, PhD, Jordan D Berlin, MD, Andrew X Zhu, MD, PhD and Eileen M O'Reilly, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

ResearchToPractice.com/GICU210 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/GICU210 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/GICU210 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Featuring interviews with Eric Van Cutsem, MD, PhD, Jordan D Berlin, MD, Andrew X Zhu, MD, PhD and Eileen M O'Reilly, MD conducted by Neil Love, MD. CME Information and Program PDF. Produced by Research To Practice.

ResearchToPractice.com/GICU210 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.

ResearchToPractice.com/GICU210 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Eileen M O'Reilly, MD conducted by Neil Love, MD. Produced by Research To Practice.